NEXALIN TECHNOLOGY, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 16th, 2022 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus • New York
Nexalin Technology, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of 2,315,000 units (the “Units”), with each Unit consisting of (a) one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and (b) one warrant to purchase one share of Common Stock (the “Warrants”) (collectively, the “Firm Units”) to the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Option”) to purchase up to an additional 347,250 shares of Common Stock, representing fifteen percent (15%) of the shares of Common Stock sold as part of the Firm Units sold in the offering (the “Option Shares”), and/or 347,250 Warrants, representing fifteen percent (15%) of the Warrants
